Diagnostic Performance of Post-Neoadjuvant MRI for Breast Pathologic Complete Response in BRCA1/2 Pathogenic-Variant Carriers
Clinical Breast Cancer · 2026-11
DOI: 10.1016/j.clbc.2026.11.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Breast Cancer, 2026-11. Verfasst von Yang Wang und 9 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, Y., Cao, K., Kou, F., Liu, H., Hu, L., Sun, J., Zhang, J., Xu, Y., Yao, L., & Xie, Y. (2026). Diagnostic Performance of Post-Neoadjuvant MRI for Breast Pathologic Complete Response in BRCA1/2 Pathogenic-Variant Carriers. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2026.11.002
Vancouver
Wang Y, Cao K, Kou F, Liu H, Hu L, Sun J, et al. Diagnostic Performance of Post-Neoadjuvant MRI for Breast Pathologic Complete Response in BRCA1/2 Pathogenic-Variant Carriers. Clinical Breast Cancer. 2026. doi:10.1016/j.clbc.2026.11.002
BibTeX
@article{Wang2026,
author = {Wang, Yang and Cao, Kun and Kou, Furong and Liu, Huimin and Hu, Li and Sun, Jie and Zhang, Juan and Xu, Ye and Yao, Lu and Xie, Yuntao},
title = {Diagnostic Performance of Post-Neoadjuvant MRI for Breast Pathologic Complete Response in BRCA1/2 Pathogenic-Variant Carriers},
journal = {Clinical Breast Cancer},
year = {2026},
doi = {10.1016/j.clbc.2026.11.002}
}
EUVIMED